Greenwich LifeSciences's total assets for Q2 2025 were $3.13M, an increase of 13.61% from the previous quarter. GLSI total liabilities were $1.69M for the fiscal quarter, a 17.18% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.